Fig. 5
From: FTO downregulation-mediated m6A modification resulting in enhanced hepatocellular carcinoma invasion
Loss of FTO indicated poor prognosis for HCC patients. (a) Based on the intensity of FTO expression levels in the nucleus as determined by immunohistochemistry, it was categorized into T1-T5, where T1 and T2 were defined as the high expression group, and T3-T5 were defined as the low expression group. (b) Patients with high FTO expression in tumor cells exhibited improved overall survival and recurrence-free survival (cohort 2, n = 323). Group differences were assessed using the Kaplan-Meier method. HCC, hepatocelluar carcinoma